Literature DB >> 8150526

Multifactorial analysis of p53 alteration in human cancer: a review.

T Soussi1, Y Legros, R Lubin, K Ory, B Schlichtholz.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8150526     DOI： 10.1002/ijc.2910570102

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  61 in total

1.  Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.

Authors:  F Citarda; G Tomaselli; R Capocaccia; S Barcherini; M Crespi
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.

Authors:  P Hammel; B Boissier; M T Chaumette; P Piedbois; N Rotman; J C Kouyoumdjian; R Lubin; J C Delchier; T Soussi
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

3.  Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patients.

Authors:  Keiji Shimizu; Yuji Ueda; Hisakazu Yamagishi
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

4.  The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma.

Authors:  Yukiharu Hiyoshi; Naoya Yoshida; Masayuki Watanabe; Junji Kurashige; Yoshifumi Baba; Yasuo Sakamoto; Hideo Baba
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

5.  Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.

Authors:  Chun-Dong Gu; Toshihiro Osaki; Tsunehiro Oyama; Masaaki Inoue; Mantaro Kodate; Kazuhito Dobashi; Takeshi Oka; Kosei Yasumoto
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

6.  Representativeness of microorgans from human colorectal tumors.

Authors:  S D Finkelstein; R Sayegh; P A Swalsky; A Bakker; R Guzman; B Rotman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

7.  Conformational effects in the p53 protein of mutations induced during chemical carcinogenesis: molecular dynamic and immunologic analyses.

Authors:  P W Brandt-Rauf; J M Chen; M J Marion; S J Smith; J C Luo; W Carney; M R Pincus
Journal:  J Protein Chem       Date:  1996-05

Review 8.  p53 gene therapy for esophageal cancer.

Authors:  Hideaki Shimada; Hisahiro Matsubara; Takenori Ochiai
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

9.  Secreted recombinant P53 protein from Pichia pastoris is a useful antigen for detection of serum p53: autoantibody in patients with advanced colorectal adenocarcinoma.

Authors:  Salma Abdelmoula-Souissi; Nourane Zouari; Imen Miladi-Abdenadher; Ouhoud Yaich-Kolsi; Ines Ayadi-Masmoudi; Abdelmajid Khabir; Hatem Masmoudi; Mounir Frikha; Raja Mokdad-Gargouri
Journal:  Mol Biol Rep       Date:  2013-03-26       Impact factor: 2.316

10.  Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma.

Authors:  Hideaki Shimada; Tooru Shiratori; Akihiko Takeda; Kazuyuki Matsushita; Shinichi Okazumi; Yasunori Akutsu; Hisahiro Matsubara; Fumio Nomura; Takenori Ochiai
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.